Diaceutics plc (DXRX)
LSE
193.00
-2.00 (-1.03%)
Closed
Oct 5, 2026
Day's Range
192.00196.90
52 wk Range
125.00197.00
Financial Statements - DXRX - Diaceutics plc
Revenue
38.43M▲ 19.5%
Net Income
97.00K▲ 105.7%Net Margin 0.3%
EBITDA
6.17M▲ 122.6%
Free Cash Flow
-5.26M▼ 32.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 38.43M | 32.15M | 23.69M | 19.50M | 13.94M | 12.69M |
| Cost of Goods | 6.95M | 3.88M | 3.99M | 2.76M | 1.71M | 3.23M |
| Gross Profit | 31.47M | 28.27M | 19.70M | 16.74M | 12.23M | 9.46M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 43K | -2.45M | -3.01M | 575K | 550K | -270K |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 302K | -1.90M | -2.43M | 564K | 462K | -682K |
| Income Tax | 205K | -205K | -692K | -160K | -99K | -945K |
| Net Income | 97K | -1.70M | -1.74M | 724K | 561K | 263K |
| EPS Basic | 0.0011 | - | -0.0207 | 0.0086 | 0.0067 | 0.0034 |
| EPS Diluted | 0.0011 | - | -0.0207 | 0.0084 | 0.0066 | 0.0034 |
| Basic Shares Outstanding | 84.58M | - | 84.22M | 84.14M | 83.93M | 77.53M |
| Diluted Shares Outstanding | 84.58M | - | 84.22M | 84.14M | 83.93M | 77.53M |
| Ebit | 360K | -1.85M | -2.37M | 684K | 550K | -631K |
| Ebitda | 6.17M | 2.77M | 2.40M | 3.69M | 2.34M | 566K |
| Net Income Continuous Operations | 302K | -1.90M | -2.43M | 564K | 462K | -682K |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
